AAAAAA

   
Results: 1-18 |
Results: 18
INTERLEUKIN-3 (IL-3), BUT NOT STEM-CELL FACTOR (SCF) INCREASES SELF-RENEWAL BY HUMAN ERYTHROID BURST-FORMING UNITS (BFU-E) IN-VITRO
Authors: LEWIS JL MARLEY SB BLACKETT NM SZYDLO R GOLDMAN JM GORDON MY
Citation: Jl. Lewis et al., INTERLEUKIN-3 (IL-3), BUT NOT STEM-CELL FACTOR (SCF) INCREASES SELF-RENEWAL BY HUMAN ERYTHROID BURST-FORMING UNITS (BFU-E) IN-VITRO, Cytokine, 10(1), 1998, pp. 49-54
ADOPTIVE IMMUNOTHERAPY FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANT - EQUAL EFFICACY OF LYMPHOCYTES FROMSIBLING AND MATCHED UNRELATED DONORS
Authors: VANRHEE F SAVAGE D BLACKWELL J ORCHARD K DAZZI F LIN F CHASE A BUNGEY J CROSS NCP APPERLEY J SZYDLO R GOLDMAN JM
Citation: F. Vanrhee et al., ADOPTIVE IMMUNOTHERAPY FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANT - EQUAL EFFICACY OF LYMPHOCYTES FROMSIBLING AND MATCHED UNRELATED DONORS, Bone marrow transplantation, 21(10), 1998, pp. 1055-1061
DONOR LYMPHOCYTE INFUSION (DLI) FOR RELAPSE OF CML AFTER ALLO-BMT - COMPARISON OF 2 REGIMENS
Authors: DAZZI F RAANANI P VANRHEE F SZYDLO R OLAVARRIA E KAEDA J APPERLEY JF CROSS NCP GOLDMAN JM
Citation: F. Dazzi et al., DONOR LYMPHOCYTE INFUSION (DLI) FOR RELAPSE OF CML AFTER ALLO-BMT - COMPARISON OF 2 REGIMENS, Bone marrow transplantation, 21, 1998, pp. 250-250
IMPACT OF RECIPIENT CMV STATUS ON OUTCOME AFTER T-DEPLETED VOLUNTEER UNRELATED DONOR (VUD) TRANSPLANTATION FOR CML
Authors: CRADDOCK C SZYDLO R WARD K YONG A BROOKES P KANFER E APPERLEY J GOLDMAN J
Citation: C. Craddock et al., IMPACT OF RECIPIENT CMV STATUS ON OUTCOME AFTER T-DEPLETED VOLUNTEER UNRELATED DONOR (VUD) TRANSPLANTATION FOR CML, British Journal of Haematology, 101, 1998, pp. 187-187
RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS FOR LEUKEMIA USING DONORS OTHER THAN HLA-IDENTICAL SIBLINGS
Authors: SZYDLO R GOLDMAN JM KLEIN JP GALE RP ASH RC BACH FH BRADLEY BA CASPER JT FLOMENBERG N GAJEWSKI JL GLUCKMAN E HENSLEEDOWNEY PJ HOWS JM JACOBSEN N KOLB HJ LOWENBERG B MASAOKA T ROWLINGS PA SONDEL PM VANBEKKUM DW VANROOD JJ VOWELS MR ZHANG MJ HOROWITZ MM
Citation: R. Szydlo et al., RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS FOR LEUKEMIA USING DONORS OTHER THAN HLA-IDENTICAL SIBLINGS, Journal of clinical oncology, 15(5), 1997, pp. 1767-1777
FACTORS INFLUENCING THE OUTCOME OF BONE-MARROW TRANSPLANTS USING UNRELATED DONORS
Authors: MADRIGAL JA SCOTT I ARGUELLO R SZYDLO R LITTLE AM GOLDMAN JM
Citation: Ja. Madrigal et al., FACTORS INFLUENCING THE OUTCOME OF BONE-MARROW TRANSPLANTS USING UNRELATED DONORS, Immunological reviews, 157, 1997, pp. 153-166
LEUKEMIA FREE SURVIVAL AFTER ALLOGENEIC TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - EFFECT OF RECLASSIFYING RESPONDERS TO DONOR LYMPHOCYTE INFUSION AS CURRENTLY FREE OF LEUKEMIA
Authors: CRADDOCK C SZYDLO R OLAVARRIA E DAZZI F VANRHEE F APPERLEY J GOLDMAN J
Citation: C. Craddock et al., LEUKEMIA FREE SURVIVAL AFTER ALLOGENEIC TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - EFFECT OF RECLASSIFYING RESPONDERS TO DONOR LYMPHOCYTE INFUSION AS CURRENTLY FREE OF LEUKEMIA, Blood, 90(10), 1997, pp. 4449-4449
EFFECT OF PRIOR INTERFERON THERAPY ON OUTCOME OF HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN FIRST CHRONIC PHASE
Authors: HOROWITZ MM GIRALT S SZYDLO R GOLDMAN J VEUMSTONE J
Citation: Mm. Horowitz et al., EFFECT OF PRIOR INTERFERON THERAPY ON OUTCOME OF HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN FIRST CHRONIC PHASE, Experimental hematology, 24(9), 1996, pp. 649-649
CYTOMEGALOVIRUS ANTIBODY AVIDITY IN ALLOGENEIC BONE-MARROW RECIPIENTS- EVIDENCE FOR PRIMARY OR SECONDARY HUMORAL RESPONSES DEPENDING ON DONOR IMMUNE STATUS
Authors: LUTZ E WARD KN SZYDLO R GOLDMAN JM
Citation: E. Lutz et al., CYTOMEGALOVIRUS ANTIBODY AVIDITY IN ALLOGENEIC BONE-MARROW RECIPIENTS- EVIDENCE FOR PRIMARY OR SECONDARY HUMORAL RESPONSES DEPENDING ON DONOR IMMUNE STATUS, Journal of medical virology, 49(1), 1996, pp. 61-65
HIGH-DOSE BUSULFAN ALONE AS CYTOREDUCTION BEFORE AUTOGRAFTING FOR CHRONIC MYELOID-LEUKEMIA - A FEASIBILITY STUDY
Authors: OBRIEN SG APPERLEY JF SZYDLO R SPENCER A RULE SA SAVAGE D BLACKWELL J ORCHARD K CHASE A HAWKINS TE GOLDMAN JM
Citation: Sg. Obrien et al., HIGH-DOSE BUSULFAN ALONE AS CYTOREDUCTION BEFORE AUTOGRAFTING FOR CHRONIC MYELOID-LEUKEMIA - A FEASIBILITY STUDY, Blood, 88(10), 1996, pp. 3528-3528
COMPARISON OF LYMPHOCYTE TRANSFUSION FROM VOLUNTEER UNRELATED AND SIBLING DONORS FOR RELEASE OF CML POST BMT
Authors: VANRHEE F SAVAGE D BLACKWELL J ORCHARD K SZYDLO R APPERLEY JF GOLDMAN JM
Citation: F. Vanrhee et al., COMPARISON OF LYMPHOCYTE TRANSFUSION FROM VOLUNTEER UNRELATED AND SIBLING DONORS FOR RELEASE OF CML POST BMT, Blood, 88(10), 1996, pp. 1022-1022
DONOR LYMPHOCYTE TRANSFUSION (DLI) FOR RELAPSE OF CML POST BMT - HIGHER CELL DOSES INDUCE MORE RAPID RESPONSES
Authors: VANRHEE F SAVAGE D BLACKWELL J ORCHARD K SZYDLO R APPERLEY JF GOLDMAN JM
Citation: F. Vanrhee et al., DONOR LYMPHOCYTE TRANSFUSION (DLI) FOR RELAPSE OF CML POST BMT - HIGHER CELL DOSES INDUCE MORE RAPID RESPONSES, Blood, 88(10), 1996, pp. 2714-2714
EFFECT OF PRIOR INTERFERON THERAPY ON OUTCOME OF HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN FIRST CHRONIC PHASE
Authors: HOROWITZ MM GIRALT S SZYDLO R GOLDMAN J VEUMSTONE J
Citation: Mm. Horowitz et al., EFFECT OF PRIOR INTERFERON THERAPY ON OUTCOME OF HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN FIRST CHRONIC PHASE, Blood, 88(10), 1996, pp. 2716-2716
RELEVANCE OF IMMUNOREACTIVE T-LYMPHOCYTE PRECURSORS IN UNRELATED BONE-MARROW TRANSPLANTATION
Authors: GOLDMAN J SPENCER A SZYDLO R KAMINSKI E BROOKES P RITTER M VANRHEE F HOWS J BATCHELOR JR LECHLER R
Citation: J. Goldman et al., RELEVANCE OF IMMUNOREACTIVE T-LYMPHOCYTE PRECURSORS IN UNRELATED BONE-MARROW TRANSPLANTATION, Experimental hematology, 23(8), 1995, pp. 742-742
WHO IS THE BEST BONE-MARROW DONOR - A COMPARISON OF HLA-MISMATCHED RELATED AND UNRELATED DONOR TRANSPLANTS FOR LEUKEMIA
Authors: HOROWITZ MM KLEIN JP ZHANG MJ SZYDLO R GOLDMAN JM
Citation: Mm. Horowitz et al., WHO IS THE BEST BONE-MARROW DONOR - A COMPARISON OF HLA-MISMATCHED RELATED AND UNRELATED DONOR TRANSPLANTS FOR LEUKEMIA, Blood, 84(10), 1994, pp. 10000393-10000393
PHENOTYPIC CHARACTERIZATION OF NORMAL AND CML CD34-POSITIVE CELLS - ONLY THE MOST PRIMITIVE CML PROGENITORS INCLUDE PH-NEG CELLS
Authors: DEFABRITIIS P DOWDING C BUNGEY J CHASE A ANGUS G SZYDLO R GOLDMAN JM
Citation: P. Defabritiis et al., PHENOTYPIC CHARACTERIZATION OF NORMAL AND CML CD34-POSITIVE CELLS - ONLY THE MOST PRIMITIVE CML PROGENITORS INCLUDE PH-NEG CELLS, Leukemia & lymphoma, 11(1-2), 1993, pp. 51-61
CHOICE OF PRETRANSPLANT TREATMENT AND TIMING OF TRANSPLANTS FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Authors: GOLDMAN JM SZYDLO R HOROWITZ MM GALE RP ASH RC ATKINSON K DICKE KA GLUCKMAN E HERZIG RH MARMONT A MASAOKA T MCGLAVE PB MESSNER H OREILLY RJ REIFFERS J RIMM AA SPECK B VEUMSTONE JA WINGARD JR ZWAAN FE BORTIN MM
Citation: Jm. Goldman et al., CHOICE OF PRETRANSPLANT TREATMENT AND TIMING OF TRANSPLANTS FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 82(7), 1993, pp. 2235-2238
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA USING SIBLING AND VOLUNTEER UNRELATED DONORS - A COMPARISON OF COMPLICATIONS IN THE 1ST 2 YEARS
Authors: MARKS DI CULLIS JO WARD KN LACEY S SZYDLO R HUGHES TP SCHWARER AP LUTZ E BARRETT AJ HOWS JM BATCHELOR JR GOLDMAN JM
Citation: Di. Marks et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA USING SIBLING AND VOLUNTEER UNRELATED DONORS - A COMPARISON OF COMPLICATIONS IN THE 1ST 2 YEARS, Annals of internal medicine, 119(3), 1993, pp. 207-214
Risultati: 1-18 |